​Triaminic, Theraflu Recalled By Novartis Over Tamper Resistance Caps​​

February 2, 2021

Novartis, the makers of Triaminic and Theraflu, has recalled the syrups due to issues with their child-resistant caps. The last batch of products in question were distributed more than a year ago, so the company believes little remains on store shelves or in use.

Triaminic, Theraflu Recalled

The Consumer Product Safety Commission said Triaminic Syrups and Theraflu Warming Relief Syrups for cough, colds and fevers were voluntarily recalled by the manufacturer, Novartis Consumer Health, because the cap could still be removed by a child even with the tamper-resistant seal in place.

Like many cold, cough and allergy medicines, Triaminic and Theraflu contain acetaminophen and diaphenhydramine. The anti-inflammatory, acetaminophen, is often used as a pain reliever and is a major ingredient in many cold and flu remedies. Diaphenhydramine is a first-generation antihistamine that is mainly used to treat allergies and colds.

Under federal law, these products have to be sealed with child-resistant packaging due to the risk of poisoning.

Novartis spokeswoman Julie Masow told CNN that there are 183 lots included in the recall - 142 of Triaminic Syrups and 41 of Theraflu Warming Relief Syrups. It is likely that very little product remains on store shelves or in homes, Masow said.

The Basel, Switzerland based company has received 12 reports of children unscrewing their locked caps. Four children ingested the product and one received medical attention.